000 | 01248 a2200349 4500 | ||
---|---|---|---|
005 | 20250517051401.0 | ||
264 | 0 | _c20160906 | |
008 | 201609s 0 0 eng d | ||
022 | _a1720-8386 | ||
024 | 7 |
_a10.1007/s40618-015-0385-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRigato, M | |
245 | 0 | 0 |
_aEffects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: a case-control study. _h[electronic resource] |
260 |
_bJournal of endocrinological investigation _cDec 2015 |
||
300 |
_a1357-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGlycated Hemoglobin _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
650 | 0 | 4 |
_aLiraglutide _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aAvogaro, A | |
700 | 1 | _aFadini, G P | |
773 | 0 |
_tJournal of endocrinological investigation _gvol. 38 _gno. 12 _gp. 1357-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40618-015-0385-5 _zAvailable from publisher's website |
999 |
_c25221418 _d25221418 |